FDA Approves Rasonque, the First Pill To Extend Survival In Advanced Pancreatic Cancer

THURSDAY, Aug. 27, 2026 — The U.S. Food and Drug Administration (FDA) has approved the first drug shown to substantially extend the lives of people with advanced pancreatic cancer, nearly doubling survival time in a key clinical trial.
The...